Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.

Japanese journal of clinical oncology - 31 May 2022

Higashigawa Satomi, Matsubayashi Hiroyuki, Kiyozumi Yoshimi, Kado Nobuhiro, Nishimura Seiichiro, Oishi Takuma, Sugino Takashi, Fushiki Kunihiro, Shirasu Hiromichi, Yasui Hirofumi, Mamesaya Nobuaki, Fukuzaki Naomi, Kunitomo Kana, Horiuchi Yasue, Kenmotsu Hirotsugu, Serizawa Masakuni

Abstract excerpt

OBJECTIVE: Since 2019, precision cancer medicine has been covered by national insurance in Japan; however, to date, germline findings have not been fully reported. The aim of this study was to evaluate the current status and raise a problem of germline finding analysis and disclosure in Japanese precision cancer medicine. METHODS: Germline findings of 52 genes were examined in 296 cases with advanced cancer by a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ Cells

Share to Germ-Line Mutation

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 35411369
DOI: 10.1093/jjco/hyac046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.PMID 35411369Read ↗

Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.Semantic proximity Read ↗

Cancer predisposition analysis and post-disclosure behaviors after screening in Japanese childrenSemantic proximity Read ↗

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.Semantic proximity Read ↗

Germline Pathogenic Variant Prediction Model for Tumor-Only Sequencing Based on Japanese Clinicogenomic Database.Semantic proximity Read ↗

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.Semantic proximity Read ↗

First report: PLATFORM study for precision treatment of rare tumors in China.Semantic proximity Read ↗

Efficacy of clinical guidelines in identifying all Japanese patients with hereditary breast and ovarian cancerSemantic proximity Read ↗

Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.Semantic proximity Read ↗

Cancer genomic medicine in JapanSemantic proximity Read ↗

Prevalence of germline pathogenic variants in cancer predisposition genes in the Japanese population.Semantic proximity Read ↗

Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.